Gates Foundation Strategic Investment Fund Logo
>
Share this page:

Portfolio

Our investments accelerate growth and stimulate private sector innovation and investment, giving our partners additional tools to effect change and improve lives. We make investments that align with foundation issue areas from vaccine development to education in the United States.

More on the types of investments we make.

Here you can explore our current and past investments, filtered by issue area or investment type.

Unicef Logo

UNICEF OPV

The foundation provided a volume guarantee to Novartis to reduce the price of oral polio virus vaccines in the developing world.

Press Release
Unicef Logo

UNICEF VII

The foundation provided support to expand UNICEF’s Vaccine Independence Initiative. This program allows countries to bridge-finance the procurement of vaccines while they await budget funds to be available.

Press Release
UStar Biotechnologies Logo

Ustar Biotechnologies

Ustar Technologies is a diagnostics company developing a tuberculosis diagnostic to increase prevention against one of the leading causes of death worldwide.

uversity logo

Uversity

Uversity is a mobile app and data solutions company that partners with colleges and universities to improve student enrollment and retention.

Case Study
Unicef Logo

Vaccine Independence Initiative (Nigeria)

The foundation provided support to UNICEF’s Vaccine Independence Initiative to ensure that Nigeria would not face stock outs of lifesaving vaccines.

Vedanta Biosciences

Vedanta Biosciences is creating a new class of drugs to modulate the human microbiome. Vedanta is pioneering the rational design of drugs made of defined consortia of bacteria that are essential dwellers of the gut ecosystem that perform critical functions Read More

News Story
VIR Logo

Vir Biotechnology

Vir Biotechnology is a newly-formed company based in San Francisco focused on finding innovative solutions to unmet needs in infectious disease.

Press Release
News Story
Visterra Logo

Visterra

Visterra is a biotechnology company that uses its proprietary platform to identify unique disease targets and design and engineer effective biological therapeutics.

Press Release
News Story

World Health Organization

The foundation’s guarantee enables WHO to secure critically-needed supplies for low- and middle-income countries in coordination with the UN Task Force for COVID by enabling WHO to issue special contracts to suppliers based on forecasted demand from countries. Investment Date: August Read More

Press Release
Zyzomyx

Zyomyx

Zyomyx is a private biotechnology company specializing in HIV CD4 diagnostics.

Case Study